Immunity to tetanus in major beta thalassemia patients.
10.7774/cevr.2015.4.2.184
- Author:
Abdolreza Sotoodeh JAHROMI
1
;
Karamatollah RAHMANIAN
Author Information
1. Zonoses Research Center, Jahrom University of Medical Sciences, Jahrom, Iran.
- Publication Type:Original Article
- Keywords:
Tetanus;
Thalassemia;
Immunity;
Antibodies
- MeSH:
Antibodies;
Bacterial Infections;
beta-Thalassemia*;
Enzyme-Linked Immunosorbent Assay;
Ferritins;
Humans;
Tetanus*;
Thalassemia
- From:Clinical and Experimental Vaccine Research
2015;4(2):184-188
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: Patients with beta thalassemia major are at increased risk for bacterial infections specially splenectomized patients. The aim of this study was to determine the anti-tetanus antibody concentration among patients with beta thalassemia major. MATERIALS AND METHODS: The anti-tetanus antibody concentration was investigated in 224 patients with thalassemia major and 224 healthy subjects matched for age and gender. Tetanus antibody and ferritin serum level were determined by enzyme-linked immunosorbent assay method using commercial kits. Subjects who had antibody level > or = 0.1 IU/mL was defined as complete protection, 0.01 to < 0.1 IU/mL as partial protection and < 0.01 IU/mL as no protection. For the analysis, we used SPSS version 11.5 software. A two-sided p-value less 0.05 was considered statistically significant. RESULTS: In patients with beta thalassemia major, antibody level against tetanus was inversely dependent about 29.3% to serum ferritin level. Thus, when serum ferritin increased 1 ng/mL, serum antibody against tetanus decreased 0.002 IU/mL. Mean anti-tetanus (IgG) antibody titers was lower in thalassemia patients compared to healthy subjects (1.53 +/- 1.71 vs. 2.02 +/- 2.05, p = 0.007) that was no significantly associated to age and gender in both study groups. All of participants had serum antibody level 0.01 IU/mL or greater. The complete protective level of anti-tetanus antibody was lower in thalassemia subjects in compare to healthy persons (71% vs. 87.9%, p < 0.001). CONCLUSION: Patients with thalassemia had lower anti-tetanus antibody level than healthy subjects. Thus the vaccine recommendation seems essential for patients with beta thalassemia major.
